Legal Action To Stop Korean Price Cuts Can't Bring Change Soon Enough

By Peter Chang / Email the Author / PharmAsia News Dec. 21, 2011 5:00 AM GMT
Korea / Word Count: 911 / Article # 28111221003

Executive Summary

Korean companies are anticipated to file complaints to stop, or at least delay drug price cuts, but the 2012 price revisions will proceed with no near-term delay in sight, the health ministry says.

Purchase this Article

$50.00 Buy Now

For $50.00, purchase this 911-word article and receive immediate online access. 100% Satisfaction Guarantee.

Already a Subscriber?

Log in for complete access.

Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.

+ Show All | – Hide All

Offers & Events

Topics Covered in this Article

Click a keyword for related articles.
Subjects
Reimbursement
Cost Effectiveness
Industries
Biopharmaceuticals
Regions
Asia-Pacific
South Korea

Log In

Email Address

Password

Remember Me

Forgot your password?

Don’t Have an Account?

If your employer has a site license, create your account to begin using it. Simply click ‘Create An Account’ button below to register now.

Otherwise, please explore our free content subscriptions.

Create an account

Enter the email address associated with your account and a temporary password will be sent to you.

Email Address

Need help? Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com

Email Article

* Required field

* To:

For multiple recipients, separate email addresses with a semi-colon.

* Your Name:

* Your Email:

Subject: Legal Action To Stop Korean Price Cuts Can't Bring Change Soon Enough

* Add a personalized message to your email:

Please Note: Only individuals with subscriptions to PharmAsia News will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.

or Cancel